After Reaching Milestone, Is ADM TRONICS UNLTD (OTCMKTS:ADMT)’s Short Interest Revealing Something?

June 20, 2017 - By Marguerite Chambers

The stock of ADM TRONICS UNLTD (OTCMKTS:ADMT) registered an increase of 709.52% in short interest. ADMT’s total short interest was 17,000 shares in June as published by FINRA. Its up 709.52% from 2,100 shares, reported previously. With 77,800 shares average volume, it will take short sellers 0 days to cover their ADMT’s short positions.

It is 0.00% or $0 reaching $0.175 per share. It is down 0.00% since June 20, 2016 and is . It has underperformed by 16.70% the S&P500.

ADM Tronics Unlimited, Inc. is a technology developer and maker of diversified lines of products. The company has market cap of $11.32 million. The Firm is engaged in the design, manufacture and sale of electronics of its own products or on a contract manufacturing basis; the production and sale of chemical and antistatic products, and research, development and engineering services. It has a 13.86 P/E ratio. The Company’s divisions include Chemical, Electronics and Engineering.

More notable recent ADM Tronics Unlimited, Inc. (OTCMKTS:ADMT) news were published by: Prnewswire.com which released: “ADM Tronics Receives Strategic Investment from Advanced Plasma Therapies” on August 10, 2015, also Prnewswire.com with their article: “ADM Tronics CEO Interviewed by OneMedMarket in Advance of Presentation at …” published on June 13, 2017, Prnewswire.com published: “FDA 510(k) Application Withdrawn for Angiodroid CO2 Injector for Angiography” on November 20, 2015. More interesting news about ADM Tronics Unlimited, Inc. (OTCMKTS:ADMT) were released by: Prnewswire.com and their article: “ADM Tronics Launches Aurex International Subsidiary with New Website” published on June 01, 2017 as well as Law360.com‘s news article titled: “Medical Device Maker Seeks To Escape Soured Sales Deal” with publication date: September 08, 2012.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.